Burning Love: big tobacco takes aim at LGBT youths.

Am J Public Health

Harvard Medical School, Boston, MA, USA.

Published: July 2002

Secret tobacco industry documents lay bare the industry's targeting, seduction, and recruitment of minority groups and children. They also unmask Big Tobacco's disdain for its targets.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222279PMC
http://dx.doi.org/10.2105/ajph.92.7.1086DOI Listing

Publication Analysis

Top Keywords

burning love
4
love big
4
big tobacco
4
tobacco takes
4
takes aim
4
aim lgbt
4
lgbt youths
4
youths secret
4
secret tobacco
4
tobacco industry
4

Similar Publications

Unmasking the Environmental Costs of In-Person General Surgery Residency Interviews.

J Surg Educ

January 2025

Department of Surgery, Division of General Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin, Milwaukee, Wisconsin. Electronic address:

Objective: As COVID-19 restrictions are eased, there has been a lively debate on whether residency recruitment interviews should be held virtually or in-person. However, environmental impact has rarely been a focus of this debate and only by inference from limited survey data. In this study, we aimed to estimate the carbon emissions generated from air-travel versus in-person interviews in the general surgery residency recruitment.

View Article and Find Full Text PDF

Background: HIV self-testing (HIVST) may facilitate marginalised populations' uptake of HIV testing, but whether the extent of marginalisation challenges individual uptake of HIVST remains under-researched. We aim to explore the perspectives of multiply marginalised cis-gender gay, bisexual and other men who have sex with men (GBMSM) and trans women on whether HIVST might increase their uptake of HIV testing.

Methods: We reanalysed qualitative interview data from SELPHI (the UK's largest HIVST randomised trial) collected between 2017 and 2020 from marginalised populations, defined as people self-identifying as non-heterosexual, transgender, non-White ethnicity and/or with low educational attainment.

View Article and Find Full Text PDF
Article Synopsis
  • A study was conducted to evaluate the effectiveness of montelukast versus a placebo in helping outpatients with mild to moderate COVID-19 recover from symptoms more quickly.
  • The trial included 1,250 participants over 30 years old with confirmed COVID-19 symptoms for less than a week, who were randomly assigned to receive either montelukast or a placebo for 14 days.
  • Results showed no significant difference in recovery time between the montelukast and placebo groups, with both groups having a median recovery time of 10 days and no reported deaths.
View Article and Find Full Text PDF

Background: Critical care beds are a limited resource, yet research indicates that recommendations for postoperative critical care admission based on patient-level risk stratification are not followed. It is unclear how prioritisation decisions are made in real-world settings and the effect of this prioritisation on outcomes.

Methods: This was a prespecified analysis of an observational cohort study of adult patients undergoing inpatient surgery, conducted in 274 hospitals across the UK and Australasia during 2017.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!